Recent Updates
Recently added Catalysts
Kynam Capital Management, LP
Track Kynam Capital Management, LP's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Aug 27, 2026
Showing 6 Stocks Out Of 31. Click On The Tickers For More Details
| Stock | Compnay Name | Shares Held | Market Value | % of Portfolio | QoQ Change |
|---|---|---|---|---|---|
 MBX | MBX BIOSCIENCES INC | 934.80 K | 51.60 M | 2.9 | |
 NRIX | NURIX THERAPEUTICS INC | 1.19 M | 28.98 M | 1.6 | |
 URGN | UROGEN PHARMA LTD | 2.43 M | 89.58 M | 5 | |
 RLAY | RELAY THERAPEUTICS INC | 3.30 M | 61.74 M | 3.4 | |
 TVTX | TRAVERE THERAPEUTICS INC | 2.00 M | 113.62 M | 6.3 | |
 CADL | CANDEL THERAPEUTICS INC | 96.74 K | 996.00 K | 0.1 |
Market Value
$ 1.80 B
Holdings
31
Period
Q2 2026
Holdings in Top 20
%
QoQ Changes
11.61 %